IC 103-2024: Case-Based Diagnosis and Management of Patellofemoral Cartilage Injuries

Availability

On-Demand

Expires on Sep 30, 2027

Cost

Member: $20.00

Resident/Fellow Member: $20.00

Affiliate Member: $20.00

Non-Member: $30.00

Credit Offered

1.5 CME Credits

1.5 Category A CEU Credits

Course Information
ADDITIONAL INFORMATION

This course includes the recording of a live Instructional Course from the 2024 AOSSM Annual Meeting which took place in Denver, CO.

IC 103: Case-Based Diagnosis and Management of Patellofemoral Cartilage Injuries

Course Description:

This case-based course will discuss diagnosis and management of symptomatic patellofemoral cartilage pathology, technical tips and expected outcomes for cartilage restoration, considerations for osteotomies, the impact of trochlear morphology, and patellofemoral arthroplasty. This interactive roundtable discussion will highlight patient selection, restoration versus arthroplasty options and discuss return to activity and sport.

Learning Objectives:

By the end of this course, participants should be able:

To review history, exam, and imaging findings that indicate symptomatic cartilage pathology of the patellofemoral joint.
To discuss indications, technical tips, post-operative management, and expected outcomes for patellofemoral cartilage restoration and arthroplasty.
To understand the indications, appropriate use, technical tips, post-operative management, and expected outcomes for adjunct procedures in the setting of patellofemoral cartilage injuries.

Faculty:

Austin V. Stone, MD
Jeffrey Guy, MD
Deryk G. Jones, MD
Joseph Liu, MD
Christian M. Lattermann, MD
Cassandra A. Lee, MD
Sabrina M. Strickland, MD
Adam Yanke, MD, PhD

Accreditation

ACCREDITATION STATEMENT The American Orthopaedic Society for Sports Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Information

AMA CREDIT DESIGNATION STATEMENT The American Orthopaedic Society for Sports Medicine designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

CLAIMING CREDIT In order to obtain AMA PRA Category 1 Credits™ participants must complete the activity and evaluation. Please note that this is an online-only activity. Participants must complete the activity and evaluation online. No hard copy submissions will be accepted.

ABOS MOC CREDIT STATEMENT: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME requirements of the American Board of Orthopaedic Surgery’s (ABOS) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABOS credit.

The American Orthopaedic Society for Sports Medicine (AOSSM) (BOC AP#: P460) is approved by the Board of Certification, Inc. to provide continuing education for Athletic Trainers. This live activity is eligible for a maximum of 1.5 Category A hours/CEUs. ATs should claim only those hours actually spent in the educational program.

Disclosures

Name	Disclosure Details
Guy, Jeffrey (MD)	No Relevant Financial Relationships
Jones, Deryk (MD)	Other Financial or Material Support relationship with Smith and Nephew; Other Financial or Material Support relationship with Mitek / Depuy; Other Financial or Material Support relationship with Arthrex; Paid Consultant relationship with Conmed / Linvatec; Speaker's Bureau/Presenter relationship with Johnson and Johnson Mitek/Depuy; Speaker's Bureau/Presenter relationship with Vericel Corporation; Speaker's Bureau/Presenter relationship with MTF Board of Trustees; Research Support relationship with Vericel Corporation; Stock or Stock Options relationship with Overture; Stock or Stock Options relationship with Conmed; Speaker's Bureau/Presenter relationship with Conmed / Linvatec; Other Financial or Material Support relationship with Fellowship support - Conmed Distributor
Lattermann, Christian (MD)	Paid Consultant relationship with Vericel; Paid Consultant relationship with Organogenesis; Paid Consultant relationship with Aesculap; Research Support relationship with JRF; Stock or Stock Options relationship with Arcuro
Lee, Cassandra (MD)	Speaker's Bureau/Presenter relationship with ConMed; Speaker's Bureau/Presenter relationship with Vericel; Speaker's Bureau/Presenter relationship with Smith and Nephew
Liu, Joseph (MD)	Paid Consultant relationship with Innocoll
Stone, Austin (MD, PhD)	Research Support relationship with Allosource; Speaker's Bureau/Presenter relationship with Vericel; Paid Consultant relationship with Bioventus; Paid Consultant relationship with Allosource; Speaker's Bureau/Presenter relationship with Bioventus
Strickland, Sabrina (MD)	Stock or Stock Options relationship with Moximed; Research Support relationship with Vericel; Research Support relationship with Miach Orthopaedics; Stock or Stock Options relationship with Stryker; Speaker's Bureau/Presenter relationship with Moximed; Stock or Stock Options relationship with Engage; Paid Consultant relationship with Moximed; Paid Consultant relationship with Vericel; Speaker's Bureau/Presenter relationship with Miach Orthopaedics; Paid Consultant relationship with Smith and Nephew Inc.; Paid Consultant relationship with Miach Orthopaedics; Speaker's Bureau/Presenter relationship with Smith and Nephew Inc.; Speaker's Bureau/Presenter relationship with Vericel
Yanke, Adam (MD, PhD)	No Relevant Financial Relationships

In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, we have implemented measures to identify and mitigate relevant financial relationships. All individuals in control of content have disclosed their financial relationships with ineligible companies within the past 24 months. These relationships have been reviewed and mitigated.

ORIGINAL RELEASE DATE: 10/01/2024
EXPIRATION DATE: 09/30/2027